Impact of end-stage renal disease and dialysis on glycemic control.
about
Comparison of glucose tolerance in renal transplant recipients and hemodialysis patientsGlycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney diseaseUpdates on the management of diabetes in dialysis patientsEstimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal DiseaseBurnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus.Pharmacotherapy of end-stage renal disease.Undiagnosed diabetes in kidney transplant candidates: a case-finding strategyDiabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative studyGlycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis.A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney DiseaseEfficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment.Linagliptin as add-on therapy to insulin for patients with type 2 diabetesPathophysiological and clinical aspects of malnutrition in chronic renal failure.Glycemic control and burnt-out diabetes in ESRD.Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes.The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.Haemodialysis-induced hypoglycaemia and glycaemic disarrays.How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting.Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease.A Prospective Study of Renal Transplant Recipients: A Fall in Insulin Secretion Underpins Dysglycemia After Renal Transplantation.Impact of Haemodialysis on Insulin Kinetics of Acute Kidney Injury Patients in Critical Care.Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis.Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study.
P2860
Q24799540-CAEFC37F-3A16-4FDB-9A5D-270F5E2731EBQ26827458-A4C222EE-4159-4B1E-A26F-1768E2D020E3Q27024782-36B6618F-E788-4C84-A2D4-7BB254D3FD65Q28972420-E4F267BF-4BEF-4137-8850-7AA20090C7E1Q30437526-86CC4724-5F38-4655-82C4-AA8572AAD79CQ33531889-1E23E245-A4E8-4456-B19A-6C8A5A039745Q33770063-7ADED6BB-F02F-4B49-BFC1-DEE4FD8A5BC4Q34609759-D5594988-8E19-403E-BF30-2076C785206EQ34984936-BAF6DC46-FBDE-4E1D-BB53-36DA1C882985Q36118969-51471D25-6B15-43A3-A616-6AE6E440EE53Q36249553-F4123F52-FB52-47B8-AB1B-8ECF5AF1911AQ36512204-FC570C5E-E832-4233-B139-E9ED734045DFQ36574084-0A7C381E-4399-4299-AAE1-A2EA49CE1791Q37281205-BADCDA45-B607-451F-939F-D7F503870AABQ37350040-2E497524-1E60-448E-B24E-2E1003920062Q37726287-DC72C0B6-150C-4F6B-B8E5-DBBA969EB2CAQ38013676-C734B46D-9102-4319-8DE2-E64C6EE9F90DQ38054558-E1CC57FD-EAC3-480F-AC45-CF3B3641154CQ38380573-B9DE0E1C-97D7-49E1-A81D-0EF0CAEC11F1Q38409082-FC42A2FF-67DA-4985-9CDD-4756335E5797Q38650054-89DF3F48-64AB-41AC-A57B-EC14AE0F7D71Q38688345-E2D35C85-83FE-4FCA-AD25-9FD8029DE595Q41676623-415961C1-0685-4CCA-A7F8-7EF7CCF7A8F4Q41765514-5ECF86A7-1A2A-4133-BF4B-BB163DA00497Q42286738-A45098B2-C945-4A50-B737-A908FA6ECDB8Q46721354-1C281745-AB10-4442-B6DA-0B4BFF0089DC
P2860
Impact of end-stage renal disease and dialysis on glycemic control.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Impact of end-stage renal disease and dialysis on glycemic control.
@en
Impact of end-stage renal disease and dialysis on glycemic control.
@nl
type
label
Impact of end-stage renal disease and dialysis on glycemic control.
@en
Impact of end-stage renal disease and dialysis on glycemic control.
@nl
prefLabel
Impact of end-stage renal disease and dialysis on glycemic control.
@en
Impact of end-stage renal disease and dialysis on glycemic control.
@nl
P2860
P1433
P1476
Impact of end-stage renal disease and dialysis on glycemic control.
@en
P2093
P2860
P356
10.1046/J.1525-139X.2000.00007.X
P577
2000-01-01T00:00:00Z